Conference Coverage
Opinion
Bariatric surgery should be considered in individuals with class 1 obesity
Nonsurgical interventions via lifestyle modifications and pharmacotherapy have not demonstrated success.
Conference Coverage
Metformin after GDM: Lessons from landmark diabetes prevention trial
WASHINGTON – Dr. Robert E. Ratner and Dr. Kim Boggess expound on the evidence base for using metformin and give their takes on postpartum clinical...
Conference Coverage
Weight loss surgery linked to lower CV event risk in diabetes
Metabolic surgery was associated with a significantly lower cumulative incidence of myocardial infarction, ischemic stroke, and mortality than...
Conference Coverage
Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CAD
Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.
Conference Coverage
Vitamin D did not reduce progression to type 2 diabetes in D2d trial
SAN FRANCISCO – Vitamin D supplementation failed to significantly reduce the risk of progression from prediabetes to...
Video
AACE 2019: Top takeaways from Yehuda Handelsman and Paul Jellinger
LOS ANGELES – Yehuda Handelsman, MD, and Paul S. Jellinger, MD, summarized some of the key takeaways from this year’...
Conference Coverage
Type 2 diabetes bumps up short-term risk for bone fracture
Evaluation of risk factors for short- and long-term fracture risk may help improve risk stratification in patients with type 2 diabetes.
Conference Coverage
No clear winner for treating neuropathic pain
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.
Conference Coverage
Lessons learned from the PCSK9 inhibitor trials
LOS ANGELES – The higher your risk, the greater your benefit from therapeutic intervention.
Conference Coverage
SGLT-2 inhibitors promising for heart failure prevention, not treatment
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.